Evaluation of tear and serum clusterin levels in thyroid ophthalmopathy patients
International Ophthalmology · 2025
DOI: 10.1007/s10792-025-03501-w ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ophthalmology, 2025. Verfasst von Mehmet Balbaba und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, Fırat University, Elazığ, Turkey. Hauptthemen laut MEDLINE: Clusterin, Tears, Graves Ophthalmopathy. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To evaluate tear and serum clusterin levels in thyroid eye disease (TED) patients. MATERIAL AND METHODS: The study included 21 patients with Graves disease with TED, 20 patients with Graves disease without TED, and 21 healthy control subjects matched for sex and age. Clusterin and lysozyme C levels of tear and serum were detected using enzyme-linked immunosorbent assays. In addition, free triiodothyronine, free thyroxine, thyroid stimulating hormone (TSH), and autoantibody (anti thyroid peroxidase, anti thyroglobulin and TSH receptor antibody) levels were measured in all groups. RESULTS: The mean concentrations of tear clusterin and lysozyme C levels were 15.99 ± 4.07 ng/mL and 54.54 ± 27.58 ng/mL in Graves patients with TED, 26,28 ± 15,98 ng/mL and 50,13 ± 46,59 ng/mL in Graves patients without TED, and 55,53 ± 45,99 ng/mL and 44,86 ± 27,42 ng/mL in control subjects, respectively. The mean concentrations of serum clusterin and lysozyme C levels were 23.15 ± 4.25 ng/mL and 93.14 ± 51.38 ng/mL in Graves patients with TED, and 26.73 ± 15.93 ng/mL and 74.22 ± 55.73 ng/mL in Graves patients without TED, and 27.47 ± 12.83 ng/mL and 76.13 ± 65.24 ng/mL in control subjects, respectively. The tear clusterin levels showed significant differences in Graves patients with and without TED than in the control group (p < 0.001). In Graves patients with TED group, tear clusterin levels were lower than in Graves patients without TED, however this difference was not statistically significant (p = 0.431). There was a statistically significant low-grade correlation between tear clusterin and clinical activity score, retraction, and Hertel measurements (range of r value: -0.299 and -0.279, and range of p values:0.024-0.034). CONCLUSION: The tear clusterin levels were decreased in Graves patients with and without TED. The results suggest that a local reduction in the amount of clusterin may play an important role in the pathogenesis of Graves disease and might be used as a local biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Faculty of Medicine, Fırat University, Elazığ, Turkey.
- Department of Ophthalmology, Faculty of Medicine, Abant Izzet Baysal University, Bolu, Turkey.
- Department of Endocrinology, Faculty of Medicine, Fırat University, Elazığ, Turkey.
- Department of Biochemistry, Faculty of Medicine, Fırat University, Elazığ, Turkey.
- Department of Ophthalmology, Kayseri State Hospital, Kayseri, Turkey. mehmetcl@hotmail.com.
Zitieren
APA
Balbaba, M., Ulaş, F., Nahırsüren Tarım, Z. N., Yıldırım, H., Kılınç, F., İlhan, N., Canleblebici, M., Erdağ, M., & Mızrak, M. (2025). Evaluation of tear and serum clusterin levels in thyroid ophthalmopathy patients. International Ophthalmology. https://doi.org/10.1007/s10792-025-03501-w
Vancouver
Balbaba M, Ulaş F, Nahırsüren Tarım ZN, Yıldırım H, Kılınç F, İlhan N, et al. Evaluation of tear and serum clusterin levels in thyroid ophthalmopathy patients. International Ophthalmology. 2025. doi:10.1007/s10792-025-03501-w
BibTeX
@article{Balbaba2025,
author = {Balbaba, Mehmet and Ulaş, Fatih and Nahırsüren Tarım, Zehra Nur and Yıldırım, Hakan and Kılınç, Faruk and İlhan, Nevin and Canleblebici, Mehmet and Erdağ, Murat and Mızrak, Mithat},
title = {Evaluation of tear and serum clusterin levels in thyroid ophthalmopathy patients},
journal = {International Ophthalmology},
year = {2025},
doi = {10.1007/s10792-025-03501-w}
}
EUVIMED